Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 6INDUSTRY 3NIH 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Hodgkin Disease 7Lymphoma 6Melanoma 4Sarcoma 2Solitary Fibrous Tumors 1HIV Infections 1

Interventions

Ifosfamide 19Doxorubicin 19Filgrastim 17Radiotherapy 13Vincristine 11Cyclophosphamide 11Etoposide 9Cisplatin 9Granulocyte Colony-Stimulating Factor 8Gene Expression Profiling 8Trabectedin 7Polymerase Chain Reaction 7Dactinomycin 6sargramostim 5etoposide phosphate 5Paclitaxel 5Mesna 5Chemotherapy, Adjuvant 4Brachytherapy 4pegfilgrastim 3Topotecan 3Microarray Analysis 3Irinotecan 3Immunohistochemistry 3Imatinib Mesylate 3Gemcitabine 3Dexrazoxane 3Base Sequence 3olaparib 2brostallicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Sarcoma × Dacarbazine × Clear all
NCT00002791 2014-01-24

Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma

Radiation Therapy Oncology Group

Phase 2 Completed
Sarcoma

Sarcoma

NCT00033644 2013-04-11

Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus

GOG Foundation

Phase 2 Terminated
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡